DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

$ API Reference Price

$ API Reference Price

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 200

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 617-05-0, Ethyl 4-hydroxy-3-methoxybenzoate, 4-hydroxy-3-methoxybenzoic acid ethyl ester, Vanillic acid, ethyl ester, Benzoic acid, 4-hydroxy-3-methoxy-, ethyl ester, 3-methoxy-4-hydroxybenzoic acid, ethyl ester

Molecular Formula

C₁₀H₁₂O₄

Molecular Weight

196.20 g/mol

InChI Key

MWAYRGBWOVHDDZ-UHFFFAOYSA-N

FDA UNII

V38JK4Z93O

1 2D Structure

Ethyl Vanillate

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

ethyl 4-hydroxy-3-methoxybenzoate

2.1.2 InChI

InChI=1S/C10H12O4/c1-3-14-10(12)7-4-5-8(11)9(6-7)13-2/h4-6,11H,3H2,1-2H3

2.1.3 InChI Key

MWAYRGBWOVHDDZ-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CCOC(=O)C1=CC(=C(C=C1)O)OC

2.2 Other Identifiers

2.2.1 UNII

V38JK4Z93O

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. 617-05-0

2. Ethyl 4-hydroxy-3-methoxybenzoate

3. 4-hydroxy-3-methoxybenzoic Acid Ethyl Ester

4. Vanillic Acid, Ethyl Ester

5. Benzoic Acid, 4-hydroxy-3-methoxy-, Ethyl Ester

6. 3-methoxy-4-hydroxybenzoic Acid, Ethyl Ester

7. M-anisic Acid, 4-hydroxy-, Ethyl Ester

8. V38jk4z93o

9. Chembl4206971

10. Nsc-8513

11. Mfcd00017269

12. Ethylvanillate

13. Nsc 8513

14. Einecs 210-503-9

15. Vanilicacidethylester; 97%

16. Brn 2100025

17. Unii-v38jk4z93o

18. Ethyl Vanilate

19. Ai3-06151

20. Ethyl 4-hydroxy-3-methoxy-benzoate

21. Vanillic Acid Ethyl

22. Vanilic Acid Ethyl Ester

23. Caffeoyl Efhylesfer,(s)

24. Vanillic Acid Ethyl Ester

25. M-anisic Acid, Ethyl Ester

26. Wln: 2ovr Dq Co1

27. 3-10-00-01413 (beilstein Handbook Reference)

28. Schembl155638

29. Dtxsid2060670

30. Ethyl 4-hydoxy-3-methoxybenzoate

31. Nsc8513

32. Chebi:181310

33. Ethyl 3-methoxy-4-hydroxybenzoate

34. Zinc394800

35. Act08390

36. Hy-b1643

37. Bdbm50450894

38. S3993

39. Akos006227599

40. Ccg-266551

41. As-14750

42. Ethyl-4-hydroxy-3-methoxybenzoate

43. Sy015808

44. Cs-0013594

45. Ft-0618640

46. V0051

47. Ethyl Vanillate, Analytical Reference Material

48. F14083

49. W-105106

50. Q27291476

2.4 Create Date

2005-03-26

3 Chemical and Physical Properties

Molecular Formula	C₁₀H₁₂O₄
Molecular Weight	196.20 g/mol
XLogP3	2.1
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	4
Rotatable Bond Count	4
Exact Mass	196.07355886 g/mol
Monoisotopic Mass	196.07355886 g/mol
Topological Polar Surface Area	55.8 Å²
Heavy Atom Count	14
Formal Charge	0
Complexity	193
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

ABOUT THIS PAGE

Find Ethyl Vanillate manufacturers, exporters & distributors on PharmaCompass

Ethyl Vanillate

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

$ API Reference Price

ACTIVE PHARMA INGREDIENTS

API REF. PRICE (USD/KG)

$ 200

MARKET PLACE

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

PATENTS & EXCLUSIVITIES

DIGITAL CONTENT

GLOBAL SALES INFORMATION

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

What are you looking for?